Femasys Inc financial data

Symbol
FEMY on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
3950 Johns Creek Court, Suite 100, Suwanee, GA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 339 % -52%
Quick Ratio 44.7 % +52.6%
Debt-to-equity 107 % +244%
Return On Equity -214 % -103%
Return On Assets -104 % -28.6%
Operating Margin -1.09K % +19.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 27.1M shares +22.9%
Common Stock, Shares, Outstanding 23.4M shares +7.84%
Entity Public Float 23.4M USD +243%
Common Stock, Value, Issued 23.5K USD +7.8%
Weighted Average Number of Shares Outstanding, Basic 22.3M shares +44.7%
Weighted Average Number of Shares Outstanding, Diluted 22.3M shares +44.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.63M USD +52%
Research and Development Expense 8.22M USD +14%
Selling and Marketing Expense 4.03M USD +520%
General and Administrative Expense 6.33M USD -7.76%
Operating Income (Loss) -17.8M USD -22.6%
Nonoperating Income (Expense) -1.02M USD -484%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -5.41M USD -35.3%
Income Tax Expense (Benefit) 1.16K USD
Net Income (Loss) Attributable to Parent -18.8M USD -32.1%
Earnings Per Share, Basic -0.85 USD/shares +8.6%
Earnings Per Share, Diluted -0.85 USD/shares +8.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.45M USD -84.1%
Accounts Receivable, after Allowance for Credit Loss, Current 488K USD +394%
Inventory, Net 3.05M USD +357%
Other Assets, Current 1.04M USD +48.9%
Assets, Current 8.02M USD -65.4%
Property, Plant and Equipment, Net 1.6M USD +43.7%
Operating Lease, Right-of-Use Asset 1.81M USD -24.1%
Other Assets, Noncurrent 955K USD -12.1%
Assets 12.4M USD -55.2%
Accounts Payable, Current 1.42M USD +24.7%
Employee-related Liabilities, Current 651K USD -39.9%
Accrued Liabilities, Current 1.15M USD -20.3%
Liabilities, Current 8.58M USD +181%
Operating Lease, Liability, Noncurrent 1.52M USD -25.4%
Liabilities 10.1M USD +7.84%
Retained Earnings (Accumulated Deficit) -127M USD -17.4%
Stockholders' Equity Attributable to Parent 2.3M USD -87.4%
Liabilities and Equity 12.4M USD -55.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.57M USD -72.5%
Net Cash Provided by (Used in) Financing Activities 778K USD
Net Cash Provided by (Used in) Investing Activities -90.2K USD -913%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 23.5M shares +7.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.45M USD -84.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 111K USD
Deferred Tax Assets, Valuation Allowance 30.8M USD +18.3%
Deferred Tax Assets, Gross 31.2M USD +17.6%
Operating Lease, Liability 2.04M USD -16.6%
Depreciation 70K USD -46.8%
Payments to Acquire Property, Plant, and Equipment 64.6K USD +625%
Property, Plant and Equipment, Gross 5.34M USD +14.6%
Operating Lease, Liability, Current 518K USD +27.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 655K USD +4%
Lessee, Operating Lease, Liability, to be Paid, Year One 629K USD +39.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 681K USD +4%
Deferred Tax Assets, Operating Loss Carryforwards 23M USD +17.1%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 708K USD +4%
Operating Lease, Payments 3.32M USD
Additional Paid in Capital 128M USD +2.98%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.25K USD -11.9%
Share-based Payment Arrangement, Expense 444K USD -34.3%
Interest Expense 525K USD +4135%